$Arterial stiffness assessment in coronary microvascular dysfunction and heart failure with preserved ejection fraction: An initial report from the WISE-CVD continuation study$

Arterial stiffness assessment in coronary microvascular dysfunction and heart failure with preserved ejection fraction: An initial report from the WISE-CVD continuation study

Background: Heart failure with preserved ejection fraction (HFpEF) is the most common cardiac complication in patients with coronary microvascular dysfunction (CMD), yet its underlying pathways remain unclear. Aortic pulse-wave velocity (aPWV) is an indicator of large artery stiffness and a predicto...

Full description

Bibliographic Details
Main Authors:	P. Rezaeian, C.L. Shufelt, J. Wei, C. Pacheco, G. Cook-Wiens, D. Berman, B. Tamarappoo, L.E. Thomson, M.D. Nelson, R.D. Anderson, J. Petersen, E.M. Handberg, C.J. Pepine, C.N. Bairey Merz
Format:	Article
Language:	English
Published:	Elsevier 2024-05-01
Series:	American Heart Journal Plus
Subjects:	Heart failure with preserve ejection fraction Pulse wave velocity Diastolic function
Online Access:	http://www.sciencedirect.com/science/article/pii/S2666602224000338

Similar Items

Progression of coronary microvascular dysfunction to heart failure with preserved ejection fraction: a case report
by: Sandy Joung, et al.
Published: (2019-05-01)

N-Terminal pro-B-type natriuretic peptide and coronary microvascular dysfunction in women with preserved ejection fraction: A report from the Women's Ischemia Syndrome Evaluation-Coronary Vascular Dysfunction (WISE-CVD) study.
by: Erika Jones, et al.
Published: (2020-01-01)

Microvascular Dysfunction in Heart Failure With Preserved Ejection Fraction
by: Domenico D’Amario, et al.
Published: (2019-11-01)

Autoimmune rheumatic diseases in women with coronary microvascular dysfunction: a report from the Women's Ischemia Syndrome Evaluation—Coronary Vascular Dysfunction (WISE-CVD) project
by: Melanie T. Chen, et al.
Published: (2023-05-01)

Latest from the WISE: Contributions to the Understanding of Ischemia and Heart Failure among Women with No Obstructive Coronary Arteries
by: Breanna Hansen, et al.
Published: (2023-03-01)

Heart failure with preserved ejection fraction (HFpEF): Implications for the anesthesiologists
by: Ajmer Singh, et al.
Published: (2018-01-01)

Temporal Trends in Angina, Myocardial Perfusion, and Left Ventricular Remodeling in Women With No Obstructive Coronary Artery Disease Over 1‐Year Follow‐Up: Results From WISE‐CVD
by: Odayme Quesada, et al.
Published: (2020-07-01)

Prognostic values of the diastolic index as a marker of chronic heart failure with preserved left ventricular ejection fraction
by: V. V. Syvolap, et al.
Published: (2024-02-01)

Pro‐Inflammatory Biomarkers in Stable Versus Acutely Decompensated Heart Failure With Preserved Ejection Fraction
by: Abraham Abernethy, et al.
Published: (2018-04-01)

Risk stratification with echocardiographic biomarkers in heart failure with preserved ejection fraction: the media echo score
by: Olivier Huttin, et al.
Published: (2021-06-01)

The role of the diastolic stress echocardiographic test in the diagnosis of heart failure with preserved left ventricular ejection fraction
by: Bošković Nikola, et al.
Published: (2023-01-01)

The Prognostic Value of the Left Ventricular End Diastolic Volume, Ejection Fraction and the Development of Dyarrhythmia in Ischemic Heart Disease.
by: Basil N. Saeed
Published: (2010-01-01)

Depression symptom patterns as predictors of metabolic syndrome and cardiac events in symptomatic women with suspected myocardial ischemia: The women's ischemia syndrome evaluation (WISE and WISE-CVD) projects
by: Nicole E Virzi, et al.
Published: (2022-01-01)

Correlation Between Serum Ferritin Levels and Echocardiographic Changes in Children with Beta-thalassaemia Major- A Cross-sectional Analytical Study
by: Eshita Das, et al.
Published: (2023-05-01)

Microvascular endothelial dysfunction in skin is associated with higher risk of heart failure with preserved ejection fraction in women with type 2 diabetes: the Hoorn Diabetes Care System Cohort
by: Elisa Dal Canto, et al.
Published: (2023-09-01)

Common Heart Failure With Preserved Ejection Fraction Animal Models Yield Disparate Myofibril Mechanics
by: Axel J. Fenwick, et al.
Published: (2024-01-01)

Trans-myocardial omega-3 fatty acid gradient in coronary microvascular dysfunction
by: Ellen C. Keeley, et al.
Published: (2022-10-01)

Cell Therapy for Heart Failure With Preserved Ejection Fraction∗
by: Barry A. Borlaug, MD, et al.
Published: (2016-01-01)

Phosphodiesterase 5 inhibitor sildenafil in patients with heart failure with preserved ejection fraction and combined pre- and postcapillary pulmonary hypertension: a randomized open-label pilot study
by: Evgeny Belyavskiy, et al.
Published: (2020-09-01)

Prognostic Impact of Hybrid Comprehensive Telerehabilitation Regarding Diastolic Dysfunction in Patients with Heart Failure with Reduced Ejection Fraction—Subanalysis of the TELEREH-HF Randomized Clinical Trial
by: Robert Irzmański, et al.
Published: (2022-03-01)

Heart Failure and Aortic Stiffening in Patients with Preserved Ejection Fraction
by: Barış Şensoy, et al.
Published: (2021-07-01)

Cardiosphere-Derived Cells Reverse Heart Failure With Preserved Ejection Fraction in Rats by Decreasing Fibrosis and Inflammation
by: Romain Gallet, MD, et al.
Published: (2016-01-01)

Perioperative implication of heart failure with normal ejection fraction
by: Arun Maheshwari, et al.
Published: (2012-01-01)

Diagnosis of diastolic dysfunction in the emergency department: really at reach for minimally trained sonologists? A call for a wise approach to heart failure with preserved ejection fraction diagnosis in the ER
by: Gabriele Via, et al.
Published: (2018-10-01)

Left atrial strain in assessing heart failure with preserved ejection fraction in hypertensive patients
by: E. S. Mazur, et al.
Published: (2022-09-01)

Coronary Artery Disease and Heart Failure With Preserved Ejection Fraction: The ARIC Study
by: Jenine E. John, et al.
Published: (2022-09-01)

Do we need a definition of acute heart failure with preserved ejection fraction?
by: Agnieszka Kapłon-Cieślicka, et al.
Published: (2021-01-01)

Development of heart failure with preserved ejection fraction is independent of eosinophils in a preclinical model
by: Qi Pan, et al.
Published: (2023-09-01)

Clinical perspectives and evidence of diastolic stress test in heart failure with preserved ejection fraction
by: Evgeny Belyavskiy, et al.
Published: (2015-12-01)

Association of mild kidney dysfunction with diastolic dysfunction and heart failure with preserved ejection fraction
by: Robin W. M. Vernooij, et al.
Published: (2024-02-01)

Effects of empagliflozin on exercise tolerance and left ventricular diastolic function in patients with heart failure with preserved ejection fraction and type 2 diabetes: a prospective single-center study
by: A. G. Ovchinnikov, et al.
Published: (2021-02-01)

Effect of Treadmill Test According to Bruce Protocol Stage 1 on Left Ventricular Diastolic Function in Patients with Exertional Dyspnea and Normal Left Ventricular Function
by: Jayanta Saha, et al.
Published: (2020-06-01)

Effect of empagliflozin on the left ventricular diastolic function in patients with type 2 diabetes mellitus and concomitant heart failure with preserved ejection fraction
by: A.S. Herashchenko, et al.
Published: (2023-09-01)

Determinants of left ventricular ejection fraction and a novel method to improve its assessment of myocardial contractility
by: Manuel Ignacio Monge García, et al.
Published: (2019-04-01)

Is heart failure misdiagnosed in hospitalized patients with preserved ejection fraction? From the European Society of Cardiology ‐ Heart Failure Association EURObservational Research Programme Heart Failure Long‐Term Registry
by: Agnieszka Kapłon‐Cieślicka, et al.
Published: (2020-10-01)

Diagnosis and Management of Patients with Heart Failure with Preserved Ejection Fraction (HFpEF): Current Perspectives and Recommendations
by: Dzhioeva O, et al.
Published: (2020-08-01)

Heart Failure with Preserved Ejection Fraction and Pulmonary Hypertension: Focus on Phosphodiesterase Inhibitors
by: Artem Ovchinnikov, et al.
Published: (2022-08-01)

Diastolic Filling Time, Chronotropic Response, and Exercise Capacity in Heart Failure and Preserved Ejection Fraction With Sinus Rhythm
by: Kazuki Kagami, et al.
Published: (2022-07-01)

Pediatric heart failure with preserved ejection fraction, a review
by: Sophie Quennelle, et al.
Published: (2023-08-01)

Coronary microvascular dysfunction as a chronic inflammatory state: Is there a role for omega-3 fatty acid treatment?
by: Ellen C. Keeley, et al.
Published: (2022-01-01)